Literature DB >> 6331551

Richter's syndrome with different immunoglobulin light chains and different heavy chain gene rearrangements.

J J van Dongen, H Hooijkaas, J J Michiels, G Grosveld, A de Klein, T H van der Kwast, M E Prins, J Abels, A Hagemeijer.   

Abstract

In a patient with Richter's syndrome, the chronic lymphocytic leukemia (CLL) expressed lambda, mu, and delta immunoglobulin (lg) chains and the non-Hodgkin lymphoma (NHL) kappa, mu, and delta lg chains. The difference in lg light chain expression suggests that the CLL and NHL are independent malignancies, or that the oncogenic event occurred in a B cell differentiation stage after the heavy chain gene rearrangements but before the selection of the light chain. Analysis of DNA by Southern blotting revealed that the lg heavy chain genes of the two malignancies were rearranged in a different way. We therefore conclude that in this patient the NHL cannot be regarded as a progression of the CLL but should most likely be considered as an independent B cell malignancy, which arose in a susceptible host.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6331551

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Composite low grade B-cell lymphomas with two immunophenotypically distinct cell populations are true biclonal lymphomas. A molecular analysis using laser capture microdissection.

Authors:  F Fend; L Quintanilla-Martinez; S Kumar; M W Beaty; L Blum; L Sorbara; E S Jaffe; M Raffeld
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

Review 2.  Richter's transformation in chronic lymphocytic leukemia.

Authors:  Apostolia-Maria Tsimberidou; Michael J Keating; William G Wierda
Journal:  Curr Hematol Malig Rep       Date:  2007-10       Impact factor: 3.952

Review 3.  Recent advances in the diagnosis and therapy of Richter's syndrome.

Authors:  Ronan Swords; John Bruzzi; Francis Giles
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

Review 4.  Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies.

Authors:  Jacques J M van Dongen; Vincent H J van der Velden; Monika Brüggemann; Alberto Orfao
Journal:  Blood       Date:  2015-05-21       Impact factor: 22.113

5.  A 72-year old man with low-grade non-Hodgkin's lymphoma, cold agglutinin hemolysis, rapidly progressive jaundice, hepatomegaly, and dyspnea.

Authors:  R W van der Hulst; J C Kluin-Nelemans; R Bieger; A Brand
Journal:  Ann Hematol       Date:  1993-11       Impact factor: 3.673

6.  Alterations in immunoglobulin genes reveal the origin and evolution of monotypic and bitypic B cell lymphomas.

Authors:  D de Jong; B M Voetdijk; G J van Ommen; P M Kluin
Journal:  Am J Pathol       Date:  1989-06       Impact factor: 4.307

7.  Centroblastic lymphoma of the thyroid supervening long-lasting chronic lymphocytic leukemia (B-CLL) demonstration of biclonality by immunohistochemical and gene rearrangement analysis.

Authors:  L Trümper; D U Matthaei-Maurer; W Knauf; P Möller
Journal:  Klin Wochenschr       Date:  1988-08-15

8.  Frequent biclonality and Ig gene alterations among B cell lymphomas that show multiple histologic forms.

Authors:  M H Siegelman; M L Cleary; R Warnke; J Sklar
Journal:  J Exp Med       Date:  1985-04-01       Impact factor: 14.307

9.  Discordant differentiation antigen pattern in a case of Richter's syndrome with monoclonal idiotype expression and immunoglobulin gene rearrangement.

Authors:  P M van Endert; G Mechtersheimer; P Möller; B Dörken; G J Hämmerling; G Moldenhauer
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640

Review 10.  EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations.

Authors:  A W Langerak; P J T A Groenen; M Brüggemann; K Beldjord; C Bellan; L Bonello; E Boone; G I Carter; M Catherwood; F Davi; M-H Delfau-Larue; T Diss; P A S Evans; P Gameiro; R Garcia Sanz; D Gonzalez; D Grand; A Håkansson; M Hummel; H Liu; L Lombardia; E A Macintyre; B J Milner; S Montes-Moreno; E Schuuring; M Spaargaren; E Hodges; J J M van Dongen
Journal:  Leukemia       Date:  2012-08-24       Impact factor: 11.528

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.